Position in DXCM
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$392,987
+$24,037 QoQ
Shares Held
5,835
-0.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#614
of 971 holders
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Sargent Investment Group, LLC holds $5,531,241 across 8 Medical Devices names. DXCM ranks #3 (7.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
30,380 | $2,756,681 | |
| 2 | MDT |
Medtronic plc
|
16,839 | $1,317,314 | |
| 3 | DXCM |
Dexcom Inc
This page
|
5,835 | $392,987 | |
| 4 | PODD |
Insulet Corp
|
2,209 | $336,320 | |
| 5 | SYK |
Stryker Corp
|
792 | $249,353 | |
| 6 | CTSO |
Cytosorbents Corp
|
555,757 | $207,853 | |
| 7 | GEHC |
GE HealthCare Technologies Inc.
|
3,143 | $201,183 | |
| 8 | LUCD |
Lucid Diagnostics Inc.
|
65,000 | $69,550 |
All Filings in DXCM
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $392,987 | 5,835 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $368,950 | 5,875 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $385,609 | 5,810 | Shares | Sole | 2026-02-13 | |
| 2025-06-30 | $1,033,077 | 11,835 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $905,866 | 13,265 | Shares | Sole | 2025-05-05 | |
| No filing history on record for this holder in this stock. | ||||||